Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids

scientific article

Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0006-291X(86)90736-9
P698PubMed publication ID3778479

P2093author name stringNagai Y
Kamata Y
Sakaguchi G
Iwamori M
Kozaki S
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectfatty acidQ61476
Clostridium botulinumQ131268
P304page(s)1015-1019
P577publication date1986-11-01
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleEvidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids
P478volume140

Reverse relations

cites work (P2860)
Q35467723Anti-GT1a IgG in Guillain-Barré syndrome.
Q40160930Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids
Q48662400Binding of Botulinum and Tetanus Neurotoxins to Ganglioside GT1b and Derivatives Thereof
Q46663715Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins
Q33869062Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors
Q36099792Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH
Q42835857Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes
Q35932883Glycosphingolipids-sweets for botulinum neurotoxin
Q36992893Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
Q42858035Interaction of botulinum and tetanus toxins with the lipid bilayer surface
Q47877385Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?
Q38252747Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes
Q38117277Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
Q37843686Receptor mimicry as novel therapeutic treatment for biothreat agents
Q41082871Structure and function of tetanus and botulinum neurotoxins.
Q48026258Two Feet on the Membrane: Uptake of Clostridial Neurotoxins
Q57808978Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics

Search more.